Impact of CD56 Continuously Recognizable as Prognostic Value of Acute Promyelocytic Leukemia: Results of Multivariate Analyses in the Japan Adult Leukemia Study Group (JALSG)-APL204 Study and a Review of the Literature.
Cancers (Basel)
; 12(6)2020 Jun 01.
Article
in En
| MEDLINE
| ID: mdl-32492981
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Cancers (Basel)
Year:
2020
Document type:
Article
Affiliation country:
Country of publication: